Article

Cataract trial weighs same-day discharge, next-day review

Fort Lauderdale, FL-Patients undergoing elective phacoemulsification can be discharged the same day and return for follow-up 2 weeks later, achieving the same results as those also seen 1 day postop, according to Christopher Tinley, MB, ChB, at the annual meeting of the Association for Research in Vision and Ophthalmology.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
Related Content
ForSight Robotics completes $125M Series B funding to address global surgeon shortage
June 25th 2025

ForSight Robotics completes $125M Series B funding to address global surgeon shortage

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Perfuse Therapeutics shares positive results from Phase 2 clinical trials of PER-001
June 25th 2025

Perfuse Therapeutics shares positive results from Phase 2 clinical trials of PER-001

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

tPA: A (new) tool in the uveitis armamentarium for patient care
June 24th 2025

tPA: A (new) tool in the uveitis armamentarium for patient care

(Image courtesy of New York Eye and Ear Infirmary of Mount Sinai) Q&A: Kira Manusis, MD, on how the Center for Refractive Solutions is redefining patient care at NYEE
June 23rd 2025

Q&A: Kira Manusis, MD, on how the Center for Refractive Solutions is redefining patient care at NYEE

© 2025 MJH Life Sciences

All rights reserved.